Dr. Sundas Khan
Overview
Sundas Khan is a Hematologist and an Oncologist in Lancaster, Pennsylvania. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Pernicious Anemia. Her top areas of expertise are DICER1 Syndrome, HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, and Familial Colorectal Cancer. Dr. Khan is currently accepting new patients.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2102 Harrisburg Pike, Lancaster, PA 17601
Additional Areas of Focus
Dr. Khan has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Medical Oncology Hematology Consultants
Jamil Khatri is a Hematologist Oncology specialist and an Oncologist in Middletown, Delaware. Dr. Khatri is rated as a Distinguished provider by MediFind in the treatment of Pernicious Anemia. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration.
Abramson Cancer Center Penn Presbyterian
Arthur Feldman is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Dr. Feldman is rated as an Advanced provider by MediFind in the treatment of Pernicious Anemia. His top areas of expertise are Pleuropulmonary Blastoma, Essential Thrombocythemia, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Schnitzler Syndrome. Dr. Feldman is currently accepting new patients.
Union Hospital Of Cecil County
Fahd Rahman is a Hematologist Oncology specialist and a Hematologist in Elkton, Maryland. Dr. Rahman is rated as a Distinguished provider by MediFind in the treatment of Pernicious Anemia. His top areas of expertise are Pulmonary Embolism, Lung Cancer, Deep Vein Thrombosis, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Rahman is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- DICER1 SyndromeDr. Khan isAdvanced. Learn about DICER1 Syndrome.
- Experienced
- Atypical Hemolytic Uremic Syndrome (aHUS)
- BRCA Positive Breast CancerDr. Khan isExperienced. Learn about BRCA Positive Breast Cancer.
- D-Plus Hemolytic Uremic SyndromeDr. Khan isExperienced. Learn about D-Plus Hemolytic Uremic Syndrome.
- Familial Colorectal CancerDr. Khan isExperienced. Learn about Familial Colorectal Cancer.
- Hemolytic-Uremic SyndromeDr. Khan isExperienced. Learn about Hemolytic-Uremic Syndrome.
- HER2 Negative Breast CancerDr. Khan isExperienced. Learn about HER2 Negative Breast Cancer.